- Home
- LGCB vs CNSP Comparison
LGCB vs CNSP Comparison
Compare LGCB & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCB
- CNSP
- Stock Information
- Founded
- LGCB 2011
- CNSP 2017
- Country
- LGCB Japan
- CNSP United States
- Employees
- LGCB N/A
- CNSP N/A
- Industry
- LGCB
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- LGCB
- CNSP Health Care
- Exchange
- LGCB Nasdaq
- CNSP Nasdaq
- Market Cap
- LGCB 6.1M
- CNSP 5.6M
- IPO Year
- LGCB 2023
- CNSP 2019
- Fundamental
- Price
- LGCB $2.38
- CNSP $0.84
- Analyst Decision
- LGCB
- CNSP Hold
- Analyst Count
- LGCB 0
- CNSP 1
- Target Price
- LGCB N/A
- CNSP N/A
- AVG Volume (30 Days)
- LGCB 15.8K
- CNSP 228.7K
- Earning Date
- LGCB 01-24-2025
- CNSP 08-13-2025
- Dividend Yield
- LGCB N/A
- CNSP N/A
- EPS Growth
- LGCB N/A
- CNSP N/A
- EPS
- LGCB N/A
- CNSP N/A
- Revenue
- LGCB $10,289,681.00
- CNSP N/A
- Revenue This Year
- LGCB N/A
- CNSP N/A
- Revenue Next Year
- LGCB N/A
- CNSP N/A
- P/E Ratio
- LGCB N/A
- CNSP N/A
- Revenue Growth
- LGCB N/A
- CNSP N/A
- 52 Week Low
- LGCB $1.22
- CNSP $0.73
- 52 Week High
- LGCB $57.05
- CNSP $148.00
- Technical
- Relative Strength Index (RSI)
- LGCB 54.64
- CNSP 38.65
- Support Level
- LGCB $2.26
- CNSP $0.73
- Resistance Level
- LGCB $2.41
- CNSP $0.84
- Average True Range (ATR)
- LGCB 0.16
- CNSP 0.07
- MACD
- LGCB -0.02
- CNSP 0.00
- Stochastic Oscillator
- LGCB 57.36
- CNSP 31.47
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.